Fertility considerations – Referral

Practice Point

Fertility considerations – Referral

Discuss fertility issues and the implications of premature menopause with all premenopausal women. Arrange early referral to a fertility specialist to maximise the opportunity for consideration of fertility preservation if appropriate and feasible.

How this guidance was developed

No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Development of this guidance was informed by a source recommendation in the EUSOMA 2012 recommendations for breast cancer in young women (Europe) based on a non-systematic review of the evidence and that was graded as low’ (using AHRQ methods) by the source guideline authors. It is also informed by a source recommendation in the ESO-ESMO 2017 and 2020 guidelines for breast cancer in young women (Europe) graded as ‘Expert Opinion’ by the source guideline authors, and which specifically indicates counselling before the onset of systemic therapy.

This recommendation aligns with the 2017 Cancer Australia Statement – Influencing best practice in breast cancer: Practice 3.

Fertility considerations – Referral

Practice Point

Discuss fertility issues and the implications of premature menopause with all premenopausal women. Arrange early referral to a fertility specialist to maximise the opportunity for consideration of fertility preservation if appropriate and feasible.

Principles in action
Image
Patient-centred care
Image
Safe and quality care
Image
Supportive care

No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Development of this guidance was informed by a source recommendation in the EUSOMA 2012 recommendations for breast cancer in young women (Europe) based on a non-systematic review of the evidence and that was graded as low’ (using AHRQ methods) by the source guideline authors. It is also informed by a source recommendation in the ESO-ESMO 2017 and 2020 guidelines for breast cancer in young women (Europe) graded as ‘Expert Opinion’ by the source guideline authors, and which specifically indicates counselling before the onset of systemic therapy.

This recommendation aligns with the 2017 Cancer Australia Statement – Influencing best practice in breast cancer: Practice 3.